ABG
Ally Bridge Group’s Xenon Pharmaceuticals XENE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-69,603
| Closed | -$2.34M | – | 35 |
|
2025
Q1 | $2.34M | Sell |
69,603
-59,688
| -46% | -$2M | 2.11% | 17 |
|
2024
Q4 | $5.07M | Sell |
129,291
-82,500
| -39% | -$3.23M | 4.35% | 5 |
|
2024
Q3 | $8.34M | Buy |
211,791
+42,422
| +25% | +$1.67M | 4.46% | 7 |
|
2024
Q2 | $6.6M | Sell |
169,369
-140,000
| -45% | -$5.46M | 3.93% | 12 |
|
2024
Q1 | $13.3M | Buy |
309,369
+67,408
| +28% | +$2.9M | 7.4% | 4 |
|
2023
Q4 | $11.1M | Sell |
241,961
-25,000
| -9% | -$1.15M | 6.64% | 5 |
|
2023
Q3 | $9.12M | Hold |
266,961
| – | – | 10.7% | 2 |
|
2023
Q2 | $10.3M | Hold |
266,961
| – | – | 12.45% | 3 |
|
2023
Q1 | $9.55M | Buy |
+266,961
| New | +$9.55M | 12.52% | 2 |
|